Income Tax Expense (Benefit) in USD of Eiger BioPharmaceuticals, Inc. from 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2012 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2023 was $2K.
  • Eiger BioPharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2023 was $6K, a 73.9% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $6K, a 73.9% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $23K, a 64.1% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $64K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $6K $2K +$5K 01 Oct 2023 31 Dec 2023 10-K 08 Apr 2024
Q3 2023 $1K $0 $0 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $1K $2K -$15K -88.2% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $16K $2K -$7K -77.8% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $23K -$3K -$21K -117% 01 Oct 2022 31 Dec 2022 10-K 08 Apr 2024
Q3 2022 $44K $0 -$16K -100% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $60K $17K +$6K +54.5% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $54K $9K -$10K -52.6% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $64K $18K +$18K 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $46K $16K +$16K 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $30K $11K +$11K 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $19K $19K +$19K 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $0 $0 $0 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2023
Q3 2020 $0 $0 $0 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $0 $0 $0 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $0 $0 $0 01 Jan 2020 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $0 $0 $0 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2022
Q3 2019 $0 $0 $0 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 $0 $0 $0 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $0 $0 $0 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $0 $0 $0 01 Oct 2018 31 Dec 2018 10-K 09 Mar 2021
Q3 2018 $0 $0 $0 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 $0 $0 $0 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 $0 $0 $0 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $0 $0 $0 01 Oct 2017 31 Dec 2017 10-K 13 Mar 2020
Q3 2017 $0 $0 $0 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 $0 $0 $0 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 $0 $0 $0 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q4 2016 $0 $0 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019
Q3 2016 $0 $0 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $0 $0 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q3 2015 $0 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 $0 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016

Eiger BioPharmaceuticals, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6K -$17K -73.9% 01 Jan 2023 31 Dec 2023 10-K 08 Apr 2024
2022 $23K -$41K -64.1% 01 Jan 2022 31 Dec 2022 10-K 08 Apr 2024
2021 $64K +$64K 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 $0 $0 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2023
2019 $0 $0 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022
2018 $0 $0 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021
2017 $0 $0 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2020
2016 $0 $0 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 $0 $0 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2018
2014 $0 $0 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2017
2013 $0 $0 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2016
2012 $0 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.